You Searched For "mrna stock" and got 20 results
Sort By:
1 min read
Moderna sinks 6% as investors continue to secure profits from massive vaccine rally
Moderna is awaiting FDA authorization after a panel of experts recommended the vaccine be approved …
Emily Graffeo
2 mins read
Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety
The decline comes with Moderna's stock having surged 693% year-to-date through Monday's close.
Ben Winck
2 mins read
Moderna skyrockets 16% to record high after FDA clears coronavirus vaccine for phase 2 study
The biotech firm aims to start a phase 3 study in the summer and begin marketing the drug as early …
Ben Winck
2 mins read
Moderna climbs 7% as Morgan Stanley says it could fill a vaccine-demand void left by Pfizer
Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses…
Emily Graffeo
2 mins read
Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says
Goldman Sachs raised the vaccine's probability of success to 75% from 70% and projected phase-two s…
Ben Winck
1 min read
These are the 5 scientists and executives getting the richest off Moderna's spike to record highs
The biotech company's shares launched as much as 30% higher on Monday after it revealed its coronav…
Ben Winck
2 mins read
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…
Matthew Fox
1 min read
Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue
The patents subject to the court's ruling cover a lipid formulation for nucleic acid delivery, whic…
Matthew Fox
2 mins read
Moderna, BioNTech tumble 19% amid report the EU is looking into COVID vaccine side effects
The EU's drug regulator is looking at reports about skin rash and kidney problems.
Carla Mozée
1 min read
Moderna climbs 12% after saying its coronavirus vaccine likely protects against new strains found in the UK and South Africa
Moderna stock jumped after the biotech company said its COVID-19 vaccine can likely protect against…
Emily Graffeo
2 mins read
A Harvard medical professor is now a billionaire after his early stake in Moderna soared 17,000%
Timothy Springer invested $5 million in the biotech company early on, and his stake has since swell…
Ben Winck
1 min read
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
2 mins read
22 biotech companies that will likely get bought as M&A heats up this summer
These are Insider's biggest healthcare stories for May 24.
Lydia Ramsey Pflanzer
2 mins read
Moderna Therapeutics, a biotech unicorn valued at more than $7.5 billion, could be gearing up for an IPO as early as this winter
Moderna is currently engaged in strategic relationships with AstraZeneca, Merck, and Vertex Pharmac…
Charlotte Hu
2 mins read
Moderna spikes 19% amid a flood of encouraging vaccine news, surpassing Merck in market value
Moderna, the almost 11 year old company that created a 95% effective pandemic ending vaccine in les…
Matthew Fox
2 mins read
Here are the top 10 most-traded stocks among retail investors this year, according to Nasdaq
Meme stocks like AMC made the list along with exchange-traded funds, according to Nasdaq's Retail T…
Natasha Dailey
1 min read
Moderna skyrockets 39% after its early trial for a coronavirus vaccine produced antibodies in all 45 patients
The company is aiming to have its coronavirus drug ready for emergency use in the fall, a breakneck…
Carmen Reinicke
2 mins read
Retail purchases of Moderna and Pfizer stock hit an 8-month high as Delta infections accelerate
Individual investors have bought a combined $180 million of stock in the COVID vaccine makers in re…
Carla Mozée
3 mins read
Moderna soars 18% after early coronavirus vaccine trial produces antibodies in all patients
A range of dosages induced immune responses and were "generally safe and well-tolerated," Moderna s…
Ben Winck
2 mins read
Moderna is sliding in its Wall Street debut after the biggest IPO in biotech history
Excluding Moderna, there have been 56 biotech IPOs that have raised a total $5.5 billion in 2018, a…